HIF1A and breast carcinoma: Because of its important role in the PI3K/Akt/mTOR signaling pathway [159], mTOR and downstream HIF-1α have been experimentally suggested to be inhibited by miR-99a, which reverses the breast cancer stem cell malignant phenotype [151].